scholarly article | Q13442814 |
P50 | author | Helmut Friess | Q15453363 |
Irene Esposito | Q65581417 | ||
Nathalia Giese | Q87716518 | ||
P2093 | author name string | Jörg Kleeff | |
Wilfried Roth | |||
Peter Schirmacher | |||
Frank Bergmann | |||
Ivane Abiatari | |||
Xined Shi | |||
P2860 | cites work | Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes | Q24315805 |
cIAP1 Localizes to the nuclear compartment and modulates the cell cycle | Q24338725 | ||
Phase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma -- CapRI: study protocol [ISRCTN62866759] | Q24792780 | ||
Apoptosis: targets in pancreatic cancer | Q24800170 | ||
Genetic alterations in pancreatic carcinoma | Q24801465 | ||
Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli | Q28116145 | ||
Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells | Q28202920 | ||
Anoikis mechanisms | Q28215553 | ||
Expression of cIAP1, a target for 11q22 amplification, correlates with resistance of cervical cancers to radiotherapy | Q28220281 | ||
The Survivin saga goes in vivo | Q28360685 | ||
NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation | Q29618715 | ||
XIAP is related to the chemoresistance and inhibited its expression by RNA interference sensitize pancreatic carcinoma cells to chemotherapeutics | Q33240542 | ||
The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas | Q33862984 | ||
Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions | Q34244725 | ||
Tenascin C and annexin II expression in the process of pancreatic carcinogenesis. | Q34490284 | ||
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer | Q34546440 | ||
Adjuvant therapy in pancreatic cancer: historical and current perspectives | Q35110205 | ||
bax, but not bcl-2, influences the prognosis of human pancreatic cancer | Q35352240 | ||
Tissue microarrays: a current medical research tool | Q35771798 | ||
Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function | Q36274969 | ||
Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control | Q36580820 | ||
Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients. | Q36616034 | ||
The correlation between cytoplasmic overexpression of epidermal growth factor receptor and tumor aggressiveness: poor prognosis in patients with pancreatic ductal adenocarcinoma | Q38447221 | ||
Multiple and synergistic deregulations of apoptosis-controlling genes in pancreatic carcinoma cells | Q38602933 | ||
The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases | Q40341729 | ||
Introduction of a survivin gene-specific small inhibitory RNA inhibits growth of pancreatic cancer cells | Q40347589 | ||
Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells. | Q40375391 | ||
Nuclear shuttling and TRAF2-mediated retention in the cytoplasm regulate the subcellular localization of cIAP1 and cIAP2. | Q40533310 | ||
Subcellular expression of c-IAP1 and c-IAP2 in colorectal cancers: relationships with clinicopathological features and prognosis | Q40601815 | ||
Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy | Q40622056 | ||
Suppression of metastatic hemangiosarcoma by a parvovirus MVMp vector transducing the IP-10 chemokine into immunocompetent mice | Q40737184 | ||
Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis | Q41460315 | ||
Cancer statistics, 2003. | Q43729872 | ||
Relationship between activation of epidermal growth factor receptor and cell dissociation in pancreatic cancer. | Q51822669 | ||
Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non-small-cell lung cancer patients. | Q52590107 | ||
ras Oncogene triggers up-regulation of cIAP2 and XIAP in intestinal epithelial cells: epidermal growth factor receptor-dependent and -independent mechanisms of ras-induced transformation. | Q53355086 | ||
Identification of cIAP1 as a candidate target gene within an amplicon at 11q22 in esophageal squamous cell carcinomas. | Q53395761 | ||
Effects and expression of TRAIL and its apoptosis-promoting receptors in human pancreatic cancer. | Q54022571 | ||
Enhanced expression of Silencer of death domains (SODD/BAG-4) in pancreatic cancer. | Q54052581 | ||
Bcl-2 expression in pancreas development and pancreatic cancer progression | Q58854740 | ||
Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors | Q74245159 | ||
Moderate activation of the apoptosis inhibitor bcl-xL worsens the prognosis in pancreatic cancer | Q77709638 | ||
Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma | Q80040456 | ||
Expression and localization of inhibitor of apoptosis proteins in normal human tissues | Q81637512 | ||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pancreatic cancer | Q212961 |
apoptotic process | Q14599311 | ||
overexpression | Q61643320 | ||
P304 | page(s) | 885-895 | |
P577 | publication date | 2006-06-14 | |
P1433 | published in | Journal of Clinical Pathology | Q6294965 |
P1476 | title | Overexpression of cellular inhibitor of apoptosis protein 2 is an early event in the progression of pancreatic cancer | |
P478 | volume | 60 |
Q38327212 | A critical assessment of the methodologies to investigate the role of inhibition of apoptosis in rodent hepatocarcinogenesis |
Q39687751 | AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-β-mediated ERK signaling |
Q36835642 | Apoptotic pathways in pancreatic ductal adenocarcinoma |
Q38815842 | Diagnostic value of selected markers and apoptotic pathways for pancreatic cancer. |
Q39171781 | Emerging role of DUBs in tumor metastasis and apoptosis: Therapeutic implication |
Q89696542 | Future Therapeutic Directions for Smac-Mimetics |
Q42147260 | Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer |
Q37573924 | Helicobacter pylori Eradication Downregulates Cellular Inhibitor of Apoptosis Protein 2 in Gastric Carcinogenesis |
Q60910119 | Human antigen R mediated post-transcriptional regulation of inhibitors of apoptosis proteins in pancreatic cancer |
Q37209606 | IAP proteins as targets for drug development in oncology |
Q37134050 | Inhibitor of apoptosis proteins and apoptosis |
Q47607136 | Inhibitors of apoptosis: clinical implications in cancer. |
Q34542571 | LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC. |
Q34960600 | MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression |
Q36094941 | Mechanism-based mathematical modeling of combined gemcitabine and birinapant in pancreatic cancer cells |
Q35143975 | Modulation of pancreatic cancer chemoresistance by inhibition of TAK1 |
Q37711135 | Molecular mechanism of pancreatic cancer--understanding proliferation, invasion, and metastasis |
Q48450830 | Multipronged quantitative proteomic analyses indicate modulation of various signal transduction pathways in human meningiomas. |
Q33841579 | Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs) |
Q92067742 | Palmitic acid stimulates NLRP3 inflammasome activation through TLR4-NF-κB signal pathway in hepatic stellate cells |
Q33636816 | Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis |
Q37980321 | Targeting IAP proteins for therapeutic intervention in cancer |
Q43077403 | Translation of cIAP2 mRNA is mediated exclusively by a stress-modulated ribosome shunt |